APO Research
Talk to an analyst

APO RESEARCH · REPORT

Percutaneous Transluminal Angioplasty Instrument

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Percutaneous Transluminal Angioplasty Instrument Market Analysis and Forecast 2026-2032

8 January 2026204 pages

Choose your research edition.

Industry ResearchPercutaneous Transluminal Angioplasty Instrument Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Percutaneous Transluminal Angioplasty Instrument Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Percutaneous Transluminal Angioplasty Instrument Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Percutaneous Transluminal Angioplasty Instrument Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Percutaneous Transluminal Angioplasty Instrument Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Percutaneous Transluminal Angioplasty Instrument market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Percutaneous Transluminal Angioplasty Instrument is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Percutaneous Transluminal Angioplasty Instrument is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Percutaneous Transluminal Angioplasty Instrument is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Percutaneous Transluminal Angioplasty Instrument is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Percutaneous Transluminal Angioplasty Instrument include Abbott, Boston Scientific, Medtronic, Terumo Medical, Lepu Medical, MicroPort, Biosensors, B.Braun and Atrium Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Percutaneous Transluminal Angioplasty Instrument, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Percutaneous Transluminal Angioplasty Instrument, also provides the revenue of main regions and countries. Of the upcoming market potential for Percutaneous Transluminal Angioplasty Instrument, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Percutaneous Transluminal Angioplasty Instrument revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Percutaneous Transluminal Angioplasty Instrument market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Percutaneous Transluminal Angioplasty Instrument revenue, projected growth trends, production technology, application and end-user industry.

Percutaneous Transluminal Angioplasty Instrument Segment by Company

Abbott

Boston Scientific

Medtronic

Terumo Medical

Lepu Medical

MicroPort

Biosensors

B.Braun

Atrium Medical

Biotronik

Asahi Intecc

Cardinal

Integer

Cook Medical

TE Connectivity

Merit

SP Medical

Percutaneous Transluminal Angioplasty Instrument Segment by Type

Introducer

Angiographic Catheter

Balloon Catheter

Guide Wire

Stent

Others

Percutaneous Transluminal Angioplasty Instrument Segment by Application

Below 40 Years Old

40 ~ 60 Years Old

Above 60 Years Old

Percutaneous Transluminal Angioplasty Instrument Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Transluminal Angioplasty Instrument market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Transluminal Angioplasty Instrument and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Transluminal Angioplasty Instrument.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Percutaneous Transluminal Angioplasty Instrument in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Percutaneous Transluminal Angioplasty Instrument company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Percutaneous Transluminal Angioplasty Instrument revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Introducer Major Player Table 3. Angiographic Catheter Major Player Table 4. Balloon Catheter Major Player Table 5. Guide Wire Major Player Table 6. Stent Major Player Table 7. Others Major Player Table 8. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Below 40 Years Old Major Player Table 10. 40 ~ 60 Years Old Major Player Table 11. Above 60 Years Old Major Player Table 12. Percutaneous Transluminal Angioplasty Instrument Industry Trends Table 13. Percutaneous Transluminal Angioplasty Instrument Industry Drivers Table 14. Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges Table 15. Percutaneous Transluminal Angioplasty Instrument Industry Restraints Table 16. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region (2021-2026) Table 19. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region (2027-2032) Table 21. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Players (2021-2026) Table 23. Global Percutaneous Transluminal Angioplasty Instrument Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Percutaneous Transluminal Angioplasty Instrument Key Players Headquarters & Area Served Table 25. Global Percutaneous Transluminal Angioplasty Instrument Players, Product Type & Application Table 26. Global Percutaneous Transluminal Angioplasty Instrument Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Percutaneous Transluminal Angioplasty Instrument by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Type (2021-2026) Table 33. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Type (2027-2032) Table 34. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2021-2026) Table 38. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2027-2032) Table 39. Abbott Company Information Table 40. Abbott Business Overview Table 41. Abbott Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 43. Abbott Recent Development Table 44. Boston Scientific Company Information Table 45. Boston Scientific Business Overview Table 46. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 48. Boston Scientific Recent Development Table 49. Medtronic Company Information Table 50. Medtronic Business Overview Table 51. Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 53. Medtronic Recent Development Table 54. Terumo Medical Company Information Table 55. Terumo Medical Business Overview Table 56. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 58. Terumo Medical Recent Development Table 59. Lepu Medical Company Information Table 60. Lepu Medical Business Overview Table 61. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 63. Lepu Medical Recent Development Table 64. MicroPort Company Information Table 65. MicroPort Business Overview Table 66. MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 68. MicroPort Recent Development Table 69. Biosensors Company Information Table 70. Biosensors Business Overview Table 71. Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 73. Biosensors Recent Development Table 74. B.Braun Company Information Table 75. B.Braun Business Overview Table 76. B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 78. B.Braun Recent Development Table 79. Atrium Medical Company Information Table 80. Atrium Medical Business Overview Table 81. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 83. Atrium Medical Recent Development Table 84. Biotronik Company Information Table 85. Biotronik Business Overview Table 86. Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 88. Biotronik Recent Development Table 89. Asahi Intecc Company Information Table 90. Asahi Intecc Business Overview Table 91. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 93. Asahi Intecc Recent Development Table 94. Cardinal Company Information Table 95. Cardinal Business Overview Table 96. Cardinal Percutaneous Transluminal Angioplasty Instrument Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 98. Cardinal Recent Development Table 99. Integer Company Information Table 100. Integer Business Overview Table 101. Integer Percutaneous Transluminal Angioplasty Instrument Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 103. Integer Recent Development Table 104. Cook Medical Company Information Table 105. Cook Medical Business Overview Table 106. Cook Medical Percutaneous Transluminal Angioplasty Instrument Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 108. Cook Medical Recent Development Table 109. TE Connectivity Company Information Table 110. TE Connectivity Business Overview Table 111. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 113. TE Connectivity Recent Development Table 114. Merit Company Information Table 115. Merit Business Overview Table 116. Merit Percutaneous Transluminal Angioplasty Instrument Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 118. Merit Recent Development Table 119. SP Medical Company Information Table 120. SP Medical Business Overview Table 121. SP Medical Percutaneous Transluminal Angioplasty Instrument Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 123. SP Medical Recent Development Table 124. North America Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Percutaneous Transluminal Angioplasty Instrument Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Country (US$ Million) & (2027-2032) Table 138. China Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026) & (US$ Million) Table 139. China Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032) & (US$ Million) Table 140. China Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026) & (US$ Million) Table 141. China Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Percutaneous Transluminal Angioplasty Instrument Image Figure 2. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Percutaneous Transluminal Angioplasty Instrument Market Size Share 2021 VS 2025 VS 2032 Figure 4. Introducer Image Figure 5. Angiographic Catheter Image Figure 6. Balloon Catheter Image Figure 7. Guide Wire Image Figure 8. Stent Image Figure 9. Others Image Figure 10. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Percutaneous Transluminal Angioplasty Instrument Market Size Share 2021 VS 2025 VS 2032 Figure 12. Below 40 Years Old Image Figure 13. 40 ~ 60 Years Old Image Figure 14. Above 60 Years Old Image Figure 15. Global Percutaneous Transluminal Angioplasty Instrument Market Size (US$ Million) & (2021-2032) Figure 16. Global Percutaneous Transluminal Angioplasty Instrument Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Percutaneous Transluminal Angioplasty Instrument Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Type (2021-2032) Figure 23. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2021-2032) Figure 26. North America Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032) Figure 28. North America Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032) Figure 29. North America Percutaneous Transluminal Angioplasty Instrument Revenue Share by Country (2021-2032) Figure 30. United States Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032) Figure 35. Europe Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032) Figure 36. Europe Percutaneous Transluminal Angioplasty Instrument Revenue Share by Country (2021-2032) Figure 37. Germany Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032) Figure 47. China Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032) Figure 48. Asia Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032) Figure 50. Asia Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032) Figure 51. Asia Percutaneous Transluminal Angioplasty Instrument Revenue Share by Region (2021-2032) Figure 52. Japan Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032) Figure 60. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032) Figure 61. SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue Share by Country (2021-2032) Figure 62. Brazil Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Percutaneous Transluminal Angioplasty Instrument Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Introducer
  • Angiographic Catheter
  • Balloon Catheter
  • Guide Wire
  • Stent
  • Others
Applications
  • Below 40 Years Old
  • 40 ~ 60 Years Old
  • Above 60 Years Old
Companies covered
  • Abbott
  • Boston Scientific
  • Medtronic
  • Terumo Medical
  • Lepu Medical
  • MicroPort
  • Biosensors
  • B.Braun
  • Atrium Medical
  • Biotronik
  • Asahi Intecc
  • Cardinal
  • Integer
  • Cook Medical
  • TE Connectivity
  • Merit
  • SP Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Percutaneous Transluminal Angioplasty Instrument Market by Type
  3. 1.2.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Introducer
  5. 1.2.3 Angiographic Catheter
  6. 1.2.4 Balloon Catheter
  7. 1.2.5 Guide Wire
  8. 1.2.6 Stent
  9. 1.2.7 Others
  10. 1.3 Percutaneous Transluminal Angioplasty Instrument Market by Application
  11. 1.3.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Below 40 Years Old
  13. 1.3.3 40 ~ 60 Years Old
  14. 1.3.4 Above 60 Years Old
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Percutaneous Transluminal Angioplasty Instrument Market Dynamics
  1. 2.1 Percutaneous Transluminal Angioplasty Instrument Industry Trends
  2. 2.2 Percutaneous Transluminal Angioplasty Instrument Industry Drivers
  3. 2.3 Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges
  4. 2.4 Percutaneous Transluminal Angioplasty Instrument Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Percutaneous Transluminal Angioplasty Instrument Market Perspective (2021-2032)
  2. 3.2 Global Percutaneous Transluminal Angioplasty Instrument Growth Trends by Region
  3. 3.2.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2021-2026)
  5. 3.2.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Players
  2. 4.1.1 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Players (2021-2026)
  3. 4.1.2 Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Percutaneous Transluminal Angioplasty Instrument Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Percutaneous Transluminal Angioplasty Instrument Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Percutaneous Transluminal Angioplasty Instrument Key Players Headquarters & Area Served
  7. 4.4 Global Percutaneous Transluminal Angioplasty Instrument Players, Product Type & Application
  8. 4.5 Global Percutaneous Transluminal Angioplasty Instrument Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Percutaneous Transluminal Angioplasty Instrument Market CR5 and HHI
  11. 4.6.3 2025 Percutaneous Transluminal Angioplasty Instrument Tier 1, Tier 2, and Tier 3
5 Percutaneous Transluminal Angioplasty Instrument Market Size by Type
  1. 5.1 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2032)
  3. 5.3 Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Type (2021-2032)
6 Percutaneous Transluminal Angioplasty Instrument Market Size by Application
  1. 6.1 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2032)
  3. 6.3 Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Boston Scientific
  8. 7.2.1 Boston Scientific Company Information
  9. 7.2.2 Boston Scientific Business Overview
  10. 7.2.3 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  12. 7.2.5 Boston Scientific Recent Developments
  13. 7.3 Medtronic
  14. 7.3.1 Medtronic Company Information
  15. 7.3.2 Medtronic Business Overview
  16. 7.3.3 Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  18. 7.3.5 Medtronic Recent Developments
  19. 7.4 Terumo Medical
  20. 7.4.1 Terumo Medical Company Information
  21. 7.4.2 Terumo Medical Business Overview
  22. 7.4.3 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  24. 7.4.5 Terumo Medical Recent Developments
  25. 7.5 Lepu Medical
  26. 7.5.1 Lepu Medical Company Information
  27. 7.5.2 Lepu Medical Business Overview
  28. 7.5.3 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  30. 7.5.5 Lepu Medical Recent Developments
  31. 7.6 MicroPort
  32. 7.6.1 MicroPort Company Information
  33. 7.6.2 MicroPort Business Overview
  34. 7.6.3 MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  35. 7.6.4 MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  36. 7.6.5 MicroPort Recent Developments
  37. 7.7 Biosensors
  38. 7.7.1 Biosensors Company Information
  39. 7.7.2 Biosensors Business Overview
  40. 7.7.3 Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  42. 7.7.5 Biosensors Recent Developments
  43. 7.8 B.Braun
  44. 7.8.1 B.Braun Company Information
  45. 7.8.2 B.Braun Business Overview
  46. 7.8.3 B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  47. 7.8.4 B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  48. 7.8.5 B.Braun Recent Developments
  49. 7.9 Atrium Medical
  50. 7.9.1 Atrium Medical Company Information
  51. 7.9.2 Atrium Medical Business Overview
  52. 7.9.3 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  54. 7.9.5 Atrium Medical Recent Developments
  55. 7.10 Biotronik
  56. 7.10.1 Biotronik Company Information
  57. 7.10.2 Biotronik Business Overview
  58. 7.10.3 Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  60. 7.10.5 Biotronik Recent Developments
  61. 7.11 Asahi Intecc
  62. 7.11.1 Asahi Intecc Company Information
  63. 7.11.2 Asahi Intecc Business Overview
  64. 7.11.3 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  66. 7.11.5 Asahi Intecc Recent Developments
  67. 7.12 Cardinal
  68. 7.12.1 Cardinal Company Information
  69. 7.12.2 Cardinal Business Overview
  70. 7.12.3 Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  72. 7.12.5 Cardinal Recent Developments
  73. 7.13 Integer
  74. 7.13.1 Integer Company Information
  75. 7.13.2 Integer Business Overview
  76. 7.13.3 Integer Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  78. 7.13.5 Integer Recent Developments
  79. 7.14 Cook Medical
  80. 7.14.1 Cook Medical Company Information
  81. 7.14.2 Cook Medical Business Overview
  82. 7.14.3 Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  84. 7.14.5 Cook Medical Recent Developments
  85. 7.15 TE Connectivity
  86. 7.15.1 TE Connectivity Company Information
  87. 7.15.2 TE Connectivity Business Overview
  88. 7.15.3 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  89. 7.15.4 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  90. 7.15.5 TE Connectivity Recent Developments
  91. 7.16 Merit
  92. 7.16.1 Merit Company Information
  93. 7.16.2 Merit Business Overview
  94. 7.16.3 Merit Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  96. 7.16.5 Merit Recent Developments
  97. 7.17 SP Medical
  98. 7.17.1 SP Medical Company Information
  99. 7.17.2 SP Medical Business Overview
  100. 7.17.3 SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (2021-2026)
  101. 7.17.4 SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  102. 7.17.5 SP Medical Recent Developments
8 North America
  1. 8.1 North America Percutaneous Transluminal Angioplasty Instrument Revenue (2021-2032)
  2. 8.2 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2032)
  3. 8.2.1 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026)
  4. 8.2.2 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032)
  5. 8.3 North America Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032)
  6. 8.4 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2032)
  7. 8.4.1 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026)
  8. 8.4.2 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032)
  9. 8.5 North America Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032)
  10. 8.6 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Country
  11. 8.6.1 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021-2026)
  13. 8.6.3 North America Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Percutaneous Transluminal Angioplasty Instrument Revenue (2021-2032)
  2. 9.2 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2032)
  3. 9.2.1 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026)
  4. 9.2.2 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032)
  5. 9.3 Europe Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032)
  6. 9.4 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2032)
  7. 9.4.1 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026)
  8. 9.4.2 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032)
  9. 9.5 Europe Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032)
  10. 9.6 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Country
  11. 9.6.1 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021-2026)
  13. 9.6.3 Europe Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Percutaneous Transluminal Angioplasty Instrument Revenue (2021-2032)
  2. 10.2 China Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2032)
  3. 10.2.1 China Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026)
  4. 10.2.2 China Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032)
  5. 10.3 China Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032)
  6. 10.4 China Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2032)
  7. 10.4.1 China Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026)
  8. 10.4.2 China Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032)
  9. 10.5 China Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Percutaneous Transluminal Angioplasty Instrument Revenue (2021-2032)
  2. 11.2 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2032)
  3. 11.2.1 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026)
  4. 11.2.2 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032)
  5. 11.3 Asia Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032)
  6. 11.4 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2032)
  7. 11.4.1 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026)
  8. 11.4.2 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032)
  9. 11.5 Asia Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032)
  10. 11.6 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Country
  11. 11.6.1 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021-2026)
  13. 11.6.3 Asia Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue (2021-2032)
  2. 12.2 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Type (2027-2032)
  5. 12.3 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Application (2027-2032)
  9. 12.5 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Country
  11. 12.6.1 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Percutaneous Transluminal Angioplasty Instrument Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst